Analyzing 2,589 child neurology telehealth encounters necessitated by the COVID-19 pandemic

Rametta, Salvatore C.; Fridinger, Sara; Gonzalez, Alexander K.; Xian, Julie; Galer, Peter D.; Kaufman, Michael S.; Prelack, Marisa S.; Sharif, Uzma; Fitzgerald, Mark P.; Melamed, Susan; Malcolm, Marissa P.; Kessler, Sudha Kilaru; Stephenson, Donna J.; Banwell, Brenda; Abend, Nicholas S.; Helbig, Ingo

doi:10.1212/wnl.0000000000010010

Cited by 120 publications

(176 citation statements)

References 14 publications

Supporting

Mentioning

157

Contrasting

Unclassified

Order By: Relevance

“…(2020) USA Descriptive Allergy & Immunology Apr. 13-May 8, 2020 177 out of 290 who received telemedicine completed satisfaction survey; 65% females Median age – 33 years old; 65% females; 41% were new patient (NP) encounters Rochester, NY Survey LOE VI Rametta et al. (2020) USA QI Pediatric Oct. 1 to Mar.…”

Section: Resultsmentioning

confidence: 99%

“…(2020) Telemedicine encounters were completed using the following third-party vendors: Epic Warp (Epic Systems Corp, Verona, Wisconsin); Skype (Skype Communications, Palo Alto, California); FaceTime (Apple Inc, Cupertino, California); and Doximity (Doximity, San Francisco, California), depending on the patient preference. RAMETTA ET AL. (2020) Audio-video telemedicine SHENOY ET AL.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Satisfaction with the use of telehealth during COVID-19: An integrative review

Andrews

Berghofer

Long

et al. 2020

International Journal of Nursing Studies Advances

191

141

View full text Add to dashboard Cite

Background The novel coronavirus (COVID-19) pandemic has defined 2020 thus far. Businesses, social and religious gatherings, travel, and almost all forms of transportation shut down to halt the spread of COVID-19. People were ordered to quarantine in place, and the world appears to go into a standstill. In the midst of being quarantined people with acute and chronic conditions still require medical care and treatment. An alternative way for people to receive needed health care was necessary. Hence, we saw an unprecedented surge in telehealth. With this unprecedented surge in use of telehealth, there is matter of delivering quality care. Objective Guided by the Donabedian Model, the purpose of this integrative review was to examine current evidence on patient and healthcare provider's satisfaction with the use of telehealth during the COVID-19 pandemic. Design An integrative review of the literature Data sources The literature review was conducted utilizing PubMED, CINAHL, Google Scholar and Cochrane Library databases. Inclusion criteria were studies published from January 2020 to July 11, 2020, published and translated in English language, and studies that evaluated patients and providers satisfaction with the use of telehealth or telemedicine during COVID-19. Eighteen articles were included in this review. Review methods An evaluation matrix was developed to collect data from the included articles. The articles were appraised using Fineout-Overholt & Gallagher-Ford Rapid Critical Appraisal Checklist for Descriptive Studies and Rapid Critical Appraisal of Evidence-Based Practice Implementation or Quality Improvement Projects (Melnyk & Fineout-Overholt, 2015). Authors independently appraised each article using the appropriate appraisal tools. Results Ten of the articles (53%) included were studies conducted in the United States. Sixteen out of 18 studies evaluated patient satisfaction and five studies examined healthcare providers’ satisfaction with the use of telehealth. The majority of telehealth services offered were by subspecialists. Overall, patients and healthcare providers have high level of satisfaction with the use of telehealth during COVID-19 pandemic. Many patients and healthcare providers reported willingness to continue using telehealth after the pandemic. Conclusion This integrative review provided additional evidence on patient and healthcare provider's satisfaction with the use of telehealth. Findings in this review may not be surprising as individuals, healthcare providers, and health systems needed to adopt the use telehealth due to necessity. However, the results for telehealth are promising.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Satisfaction with the use of telehealth during COVID-19: An integrative review

Andrews

Berghofer

Long

et al. 2020

International Journal of Nursing Studies Advances

191

141

View full text Add to dashboard Cite

show abstract

“…Most (86%) reported intending to pursue telehealth in future encounters. 25 An international survey of pediatric neurologists treating children with epilepsy revealed that about 25% of practitioners were seeing outpatients exclusively with telehealth and 95% were seeing at least some patients by telehealth. 26 A US-based single hospital system evaluation revealed that 67% of outpatient visits were completed via telehealth, 32% with phone visits, and only 1% of visits were in-person clinic encounters.…”

Section: Discussionmentioning

confidence: 99%

The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society Membership

et al. 2020

View full text Add to dashboard Cite

The COVID-19 pandemic has impacted the delivery of care to people with epilepsy (PWE) in multiple ways including limitations on in-person contact and restrictions on neurophysiological procedures. To better study the effect of the pandemic on PWE, members of the American Epilepsy Society were surveyed between April 30 and June 14, 2020. There were 366 initial responses (9% response rate) and 337 respondents remained for analysis after screening out noncompleters and those not directly involved with clinical care; the majority were physicians from the United States. About a third (30%) of respondents stated that they had patients with COVID-19 and reported no significant change in seizure frequency. Conversely, one-third of respondents reported new onset seizures in patients with COVID-19 who had no prior history of seizures. The majority of respondents felt that there were at least some barriers for PWE in receiving appropriate clinical care, neurophysiologic procedures, and elective surgery. Medication shortages were noted by approximately 30% of respondents, with no clear pattern in types of medication involved. Telehealth was overwhelmingly found to have value. Among the limitation of the survey was that it was administered at a single point in time in a rapidly changing pandemic. The survey showed that almost all respondents were affected by the pandemic in a variety of ways.

show abstract

“…A recent survey of telemedicine use in a child neurology clinic showed a high satisfaction rate among both patients and caregivers. Racial disparities in the delivery of remote health care were also identified, with minorities more likely to use telephone rather than video services (Rametta et al 2020). With time, iteration, and revision, telemedicine delivery will likely improve substantially and may, in fact, sustain even after restrictions have been lifted to replace in-person visits for those families who live remotely or are distanced from expert medical centres.…”

Section: Health Carementioning

confidence: 99%

Changes in access to educational and healthcare services for individuals with intellectual and developmental disabilities during COVID‐19 restrictions

Jeste¹,

Hyde²,

DiStefano³

et al. 2020

J intellect Disabil Res

247

212

View full text Add to dashboard Cite

Background COVID-19 restrictions have significantly limited access to in-person educational and healthcare services for all, including individuals with intellectual and developmental disabilities (IDDs). The objectives of this online survey that included both national and international families were to capture changes in access to healthcare and educational services for individuals with IDDs that occurred shortly after restrictions were initiated and to survey families on resources that could improve services for these individuals. Methods This was an online survey for caregivers of individuals with (1) a genetic diagnosis and (2) a neurodevelopmental diagnosis, including developmental delay, intellectual disability, autism spectrum disorder or epilepsy. The survey assessed (1) demographics, (2) changes in access to educational and healthcare services and (3) available and preferred resources to help families navigate the changes in service allocation. Results Of the 818 responses (669 within the USA and 149 outside of the USA), most families reported a loss of at least some educational or healthcare services. Seventy-four per cent of parents reported that their child lost access to at least one therapy or education service, and 36% of respondents lost access to a healthcare provider. Only 56% reported that their child received at least some continued services through tele-education. Those that needed to access healthcare providers did so primarily through telemedicine. Telehealth (both tele-education and telemedicine) was reported to be helpful when available, and caregivers most often endorsed a need for an augmentation of these remote delivery services, such as 1:1 videoconference sessions, as well as increased access to 1:1 aides in the home. Conclusions COVID-19 restrictions have greatly affected access to services for individuals with syndromic IDDs. Telehealth may provide opportunities for delivery of care and education in a sustainable way, not only as restrictions endure but also after they have been lifted.

show abstract

Analyzing 2,589 child neurology telehealth encounters necessitated by the COVID-19 pandemic

Cited by 120 publications

References 14 publications

Satisfaction with the use of telehealth during COVID-19: An integrative review

Satisfaction with the use of telehealth during COVID-19: An integrative review

The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society Membership

Changes in access to educational and healthcare services for individuals with intellectual and developmental disabilities during COVID‐19 restrictions

Contact Info

Product

Resources

About